Research News and Research

RSS

Bipartisan deficit commission unlikely to make big Medicare changes

National Journal: "For all of the attention surrounding President Obama's bipartisan commission on deficit reduction, the country's biggest cost centers — health care in general and Medicare specifically — will likely remain unscathed when the panel offers its recommendations in December.

1 Oct 2010

Health insurance prices, restrictions now on federal consumer website

Kaiser Health News staff writer Jessica Marcy talked with Todd Park, the chief technology officer of the Department of Health and Human Services, and Karen Pollitz, who heads the consumer support division at HHS Office of Consumer Information and Insurance Oversight, about the detailed health plan cost and benefits information unveiled today on Healthcare.gov.

1 Oct 2010

Political cartoon: 'Don't Worry'

Kaiser Health News provides a fresh take on health policy developments with "Don't Worry" by Chip Bok.

1 Oct 2010

Med schools say doctor shortage to worsen under new health law

The new health law will worsen the physician shortage as newly insured patients seek care, according to a new report from the Association of American Medical Colleges.

1 Oct 2010

Merck to pay millions over Mass. allegations of inflated wholesale rate

Bloomberg Businessweek: A Massachusetts court ordered the drug maker Merck to pay $4.6 million in damages for inflating wholesale prices for generic asthma drugs. "Massachusetts claimed the companies reported inflated wholesale acquisition-cost prices for the generics, and that MassHealth, the state component of the Medicaid program, would rely on those prices for reimbursements" (McQuillen, 9/30).

1 Oct 2010

Today's OpEds: Sebelius' tough talk; Changing the malpractice system; Different perspectives on the health overhaul

The problem is, quite simply, the centerpiece of the entire health care overhaul -- guaranteed coverage for so-called "preexisting" conditions. As long as both parties insist on this, the national discussion over real health care reform is going nowhere (Jason Lewis, 9/30).

1 Oct 2010

Encorium announces extension of expiration date for pending rights offering

Encorium Group, Inc. , a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced that it has extended the expiration date for its pending rights offering from September 30, 2010 to October 15, 2010. The subscription rights may now be exercised at any time prior to 5:00 p.m. ET on Friday, October 15, 2010.

1 Oct 2010

Siblings of children with autism have language delays: Study

Siblings of children with autism have more frequent language delays and other subtle characteristics of the disorder than previously understood. Girls also may be mildly affected more often than recognized in the past.

1 Oct 2010

Activating rearrangements in receptor genes are more common than previously thought

A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,--an MSKCC surgeon, researcher and the Director of the Brain Tumor Center--and was published in the October 1 issue of the journal Genes & Development.

1 Oct 2010

Vibrant joins Bike MS NYC to raise money for National Multiple Sclerosis Society

Vibrant will participate in Bike MS NYC on Sunday, October 3 to increase awareness of Multiple Sclerosis and to raise money for the National Multiple Sclerosis Society. The race, hosted by the Southern NY Chapter of the National Multiple Sclerosis Society, will include nearly 6,000 cyclists across two Bike MS NYC locations.

1 Oct 2010

Medicago announces official groundbreaking ceremony for U.S. plant-based commercial grade vaccine facility

Medicago U.S.A. Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that company executives, along with U.S. Senator Kay Hagan (D-NC) and U.S. Congressman David Price (D-NC), are holding an official groundbreaking ceremony this morning for its U.S. plant-based commercial grade vaccine facility in Research Triangle Park, North Carolina.

1 Oct 2010

After McDonald's flap, White House says it will exercise 'discretion' on medical loss ratios

The Wall Street Journal: The Obama administration said Thursday that Health and Human Services Secretary Kathleen Sebelius will "exercise her discretion" in enforcing the medical loss ratio requirement of the health law. The comment comes after a report in The Journal Thursday that "McDonald's warned federal regulators it could drop its health-insurance plan for nearly 30,000 restaurant workers unless regulators waive a new requirement of the health overhaul.

1 Oct 2010

LSUHSC-S receives $3.9M NIDA grant to develop EMB-001 drug for cocaine dependence

Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for addiction and obesity, announced today that the Louisiana State University Health Sciences Center (LSUHSC-S) has received a $3.9 million dollar grant from the National Institute on Drug Abuse (NIDA). The grant will support the next stages of development for Embera's drug candidate EMB-001 to treat cocaine dependence, as well as advance EMB-001 into clinical testing.

1 Oct 2010

CVS/pharmacy's fundraising campaign raises $4.1 million for ALS research

In just 21 days, CVS/pharmacy's ninth annual in-store fundraising campaign to support the fight against amyotrophic lateral sclerosis (ALS) brought in $4.1 million. The funds raised by the campaign will be donated to the Boston-based ALS Therapy Alliance (ATA) to support the funding of new clinical research aimed at developing new therapies for ALS patients and focused on the ultimate goal of finding a cure for ALS.

1 Oct 2010

Benicar better than Cozaar in reducing blood pressure: Study

New study results show that patients treated with Benicar® (olmesartan medoxomil) 40 mg once daily had significantly greater reductions in blood pressure and higher rates of goal attainment than patients receiving Cozaar® (losartan potassium) 100 mg once daily at week 8, according to findings of a new head-to-head study presented today at the late breaker session at the 23rd Scientific Meeting of the International Society of Hypertension (ISH) in Vancouver, Canada.

1 Oct 2010

Cortex regains global rights to AMPAKINE compounds for treatment of schizophrenia and depression

Cortex Pharmaceuticals, Inc. announced that it has regained worldwide rights to develop and commercialize its AMPAKINE® compounds for the treatment of schizophrenia and depression.

1 Oct 2010

BUSM to create Center for Health Insurance Reform, Cardiovascular Outcomes and Disparities

Boston Medical Center (BMC) has been awarded a four year, $5.7 million grant from the National Heart, Lung and Blood Institute (NHLBI) for investigators from Boston University School of Medicine (BUSM) to create the Center for Health Insurance Reform, Cardiovascular Outcomes and Disparities.

1 Oct 2010

Increase in levels of P450 protein creates EET molecules that lower blood pressure

If you are one of the millions of Americans with high blood pressure, more help is on the way. That's because a new research study published in the October 2010 print issue of The FASEB Journal shows that a protein, called P450, metabolizes arachidonic acid in our blood vessel walls to create a tiny molecule with a big name-epoxyeicosatrienoic acid (EET)-which in mice, turns off genes responsible for vascular inflammation and ultimately relaxes blood vessels to lower blood pressure. This protein and genes are also present in humans.

1 Oct 2010

GSA urges treatment of sepsis as a medical emergency

The Global Sepsis Alliance (GSA) is urging healthcare providers, patients and policymakers worldwide to treat sepsis as a medical emergency. "Tens of millions of people die from sepsis each year, making it the likely leading cause of death worldwide. Sepsis kills regardless of age, ethnicity, location and access to care," said Konrad Reinhart, M.D., Chairman of the GSA and director of the Department of Anesthesiology and Intensive Care Medicine, University Hospital of the Friedrich Schiller, University of Jena, Germany.

1 Oct 2010

First Edition: October 1, 2010

In this morning's headlines -- Medicaid enrollment spikes and the interplay between the federal government and McDonald's gets more attention.

1 Oct 2010

Research News and Research

Bipartisan deficit commission unlikely to make big Medicare changes

Health insurance prices, restrictions now on federal consumer website

Political cartoon: 'Don't Worry'

Med schools say doctor shortage to worsen under new health law

Merck to pay millions over Mass. allegations of inflated wholesale rate

Today's OpEds: Sebelius' tough talk; Changing the malpractice system; Different perspectives on the health overhaul

Encorium announces extension of expiration date for pending rights offering

Siblings of children with autism have language delays: Study

Activating rearrangements in receptor genes are more common than previously thought

Vibrant joins Bike MS NYC to raise money for National Multiple Sclerosis Society

Medicago announces official groundbreaking ceremony for U.S. plant-based commercial grade vaccine facility

After McDonald's flap, White House says it will exercise 'discretion' on medical loss ratios

LSUHSC-S receives $3.9M NIDA grant to develop EMB-001 drug for cocaine dependence

CVS/pharmacy's fundraising campaign raises $4.1 million for ALS research

Benicar better than Cozaar in reducing blood pressure: Study

Cortex regains global rights to AMPAKINE compounds for treatment of schizophrenia and depression

BUSM to create Center for Health Insurance Reform, Cardiovascular Outcomes and Disparities

Increase in levels of P450 protein creates EET molecules that lower blood pressure

GSA urges treatment of sepsis as a medical emergency

First Edition: October 1, 2010

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories